TY - JOUR
T1 - Insuffisance rénale aiguë et paludisme grave chez l'adulte : étude descriptive monocentrique à Madagascar en utilisant les critères KDIGO
AU - Randrianarisoa, Rova Malala Fandresena
AU - Ranivoharisoa, Eliane Mikkelsen
AU - Ahmed, Mohamed
AU - Ramilitiana, Benja
AU - Rakotomalala, Nancy Lorena
AU - Randra, Mamy Jean de Dieu
AU - Randriamarotia, Willy Franck Harilalaina
N1 - Funding Information: Les auteurs remercient le service des Maladies infectieuses du Centre hospitalier universitaire Joseph Raseta Befelatanana, Antananarivo. Ils remercient ?galement Monsieur Rija Benjamina Andrianandrianina Rakotoarinelina pour son aide pr?cieuse dans l'application informatis?e de la formule d'ADQI. Cette recherche n'a b?n?fici? d'aucune subvention sp?cifique ?manant d'organismes de financements publics, commerciaux ou ? but non lucratif. Publisher Copyright: © 2021 Société francophone de néphrologie, dialyse et transplantation
PY - 2021/10
Y1 - 2021/10
N2 - Introduction: Acute Kidney Injury (AKI) is one of the criteria for severe malaria with a varied incidence. Our objectives are to determine the prevalence of malaria-associated AKI and to report the characteristics of patients with the evolution of cases. Patients and method: This is a 5-year retrospective descriptive study from January 1, 2015 to December 31, 2019 in the Infectious Diseases department of the University Hospital Center of Befelatanana Antananarivo. Among 379 patients diagnosed, 103 patients (27,18%) with associated AKI were included. We used the criteria of Kidney Disease Improving Global Outcomes group to define AKI. Results: The prevalence of AKI was 27.18%. The mean age of patients was 34.92 years and the sex-ratio was 3.68. Plasmodium falciparum was the causative agent in 98.06% of cases followed by Plasmodium vivax. Diuresis was preserved in 69.86% of cases. Jaundice was the main sign of severity associated (49.51%). The mean creatinine level was 466.93 μmol/L. The evolution was favorable under antimalarial drug and rehydration. Dialysis was required in 25.24% of cases. Thirteen patients had died, a rate of 12.62%, of which 8 patients (61.54%) had dialysis criteria but had not been purged for economic reasons. Conclusion: AKI is a frequent complication of malaria. It is responsible for significant mortality despite improved care in the fight against malaria.
AB - Introduction: Acute Kidney Injury (AKI) is one of the criteria for severe malaria with a varied incidence. Our objectives are to determine the prevalence of malaria-associated AKI and to report the characteristics of patients with the evolution of cases. Patients and method: This is a 5-year retrospective descriptive study from January 1, 2015 to December 31, 2019 in the Infectious Diseases department of the University Hospital Center of Befelatanana Antananarivo. Among 379 patients diagnosed, 103 patients (27,18%) with associated AKI were included. We used the criteria of Kidney Disease Improving Global Outcomes group to define AKI. Results: The prevalence of AKI was 27.18%. The mean age of patients was 34.92 years and the sex-ratio was 3.68. Plasmodium falciparum was the causative agent in 98.06% of cases followed by Plasmodium vivax. Diuresis was preserved in 69.86% of cases. Jaundice was the main sign of severity associated (49.51%). The mean creatinine level was 466.93 μmol/L. The evolution was favorable under antimalarial drug and rehydration. Dialysis was required in 25.24% of cases. Thirteen patients had died, a rate of 12.62%, of which 8 patients (61.54%) had dialysis criteria but had not been purged for economic reasons. Conclusion: AKI is a frequent complication of malaria. It is responsible for significant mortality despite improved care in the fight against malaria.
KW - Acute kidney injury
KW - Kidney Disease Improving Global Outcomes criteria
KW - Madagascar
KW - Malaria
UR - http://www.scopus.com/inward/record.url?scp=85106663716&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.nephro.2021.03.003
DO - https://doi.org/10.1016/j.nephro.2021.03.003
M3 - Article
C2 - 34045125
SN - 1769-7255
VL - 17
SP - 434
EP - 440
JO - Nephrologie et Therapeutique
JF - Nephrologie et Therapeutique
IS - 6
ER -